BIBF 1202

CAS No. 894783-71-2

BIBF 1202( —— )

Catalog No. M29632 CAS No. 894783-71-2

BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 791 Get Quote
10MG 1186 Get Quote
25MG 2131 Get Quote
50MG 3198 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BIBF 1202
  • Note
    Research use only, not for human use.
  • Brief Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).
  • Description
    BIBF 1202 is a VEGFR2 kinase inhibitor (IC50 = 62 nM).(In Vitro):BIBF 1202 is produced in the main metabolic pathway of BIBF 1120 by the cleavage of methyl esters. Then, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acyl glucuronide .
  • In Vitro
    The major metabolic pathway for BIBF 1120 is methyl ester cleavage to BIBF 1202. Subsequently, the free carboxyl group of BIBF 1202 is glucuronidated to 1-O-acylglucuronide.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    894783-71-2
  • Formula Weight
    525.609
  • Molecular Formula
    C30H31N5O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 45 mg/mL (85.62 mM)
  • SMILES
    CN(C(=O)CN1CCN(C)CC1)c1ccc(N\C(=C2/C(=O)Nc3cc(ccc23)C(O)=O)c2ccccc2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Ellipticine

    Ellipticine is a potent antineoplastic agent exhibiting multiple mechanisms of action.

  • Regorafenib

    A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).

  • UNC0064-12

    2,4-Pyrimidinediamine with linker is a patent compound in WO2013055780A1.